NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ALIM - Alimera Sciences Inc

Alimera Sciences, Inc., incorporated on June 4, 2003, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is focused on diseases affecting the back of the eye, or retina. Its most advanced product candidate is Iluvien, which the Company is developing for the treatment of diabeti","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ALIMhart

Alimera Sciences Inc News


Alimera Sciences Inc (NASDAQ:ALIM) Cheers on First-Quarter Results- ALIM, PFE ...
eStocksDaily - May 14, 2012
Alimera Sciences Inc (NASDAQ:ALIM) moved up 3.76 percent to $2.76 following the firm reported Q1 results. Research and development expenses were $1.6 million evaluated to $1.8 million in the Q1 of 2011.

Healthcare Stocks: Arena Top Winner (ALR, GOLD, ARNA, RDY, ALIM)
Gaining Green - May 11, 2012
By Gaining Green Staff Alere Inc (NYSE:ALR) decreased 11.93% to $19.64. Canaccord Genuity maintained buy rating on the stock and the price target from $35 to $30.

US Companies Reporting Midmorning EPS, May 11
BusinessWeek - May 11, 2012
By Wendy Soong on May 11, 2012 The following table lists the 77 US companies that reported quarterly earnings today (end date of the quarter is noted in the last column).

Alimera Sciences Reports First Quarter 2012 Financial Results
MarketWatch (press release) - May 11, 2012
ATLANTA, May 11, 2012 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc., (NASDAQ:ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced ...

Earnings Scheduled For May 11
Benzinga - May 11, 2012
By Monica Gerson NVIDIA Corporation (NASDAQ: NVDA) is projected to post its Q1 EPS at $0.10 on revenue of $916.17 million. Cache Inc (NASDAQ: CACH) is estimated to post a Q1 loss at 0.09 per share on revenue of $54.64 million.

United Kingdom Grants ILUVIEN(R) Marketing Authorization for the Treatment of ...
MarketWatch (press release) - May 7, 2012
ATLANTA, May 7, 2012 (GlobeNewswire via COMTEX) -- Alimera Sciences, Inc., (NASDAQ:ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, ...
Psivida, Alimera eye drug gets UK marketing nod - Reuters UK

Alimera Sciences CEO Daniel Myers Took 63% Pay Cut in 2011 - cbl
Citybizlist (press release) - May 1, 2012
By Bill Murphy ALPHARETTA, Ga. - Alimera Sciences Inc. (Nasdaq:ALIM) CEO C. Daniel Myers' pay slid 63 percent to $492557 million last year, according to an SEC filing.

Alimera - Eyeing EU Market
RTT News - Apr 30, 2012
(RTTNews) - There's an adage that says "eyes are the windows to the soul". But to medical researchers, eyes are windows to health because some diseases could be detected just by looking at our eyes.

Alimera Sciences to Release First Quarter Fiscal Year 2012 Financial Results
MarketWatch (press release) - Apr 26, 2012
ATLANTA, Apr 26, 2012 (GlobeNewswire via COMTEX) -- Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, ...
ALIMERA SCIENCES INC : Alimera Sciences to Release First Quarter Fiscal Year ... - 4-traders

Tuesday's NASDAQ Top % Gainers: IBCP, ALIM, ALGN, LNET
InvestorIdeas.com (press release) - Apr 25, 2012
New York, NY - April 25, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday, April 24th.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>